# DyeVert System and Contrast-induced Acute Kidney Injury

Study · id `cardio:ct-nct04714736` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04714736](<https://clinicaltrials.gov/study/NCT04714736>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04714736

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 522 participants.

## Technical summary

Registry record NCT04714736. Randomized; single masking; primary purpose prevention. Start 2020-02-10 (actual); primary completion 2022-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 522 participants (enrolled count; ClinicalTrials.gov record NCT04714736, source copy `cardio:ctgov-nct04714736-2024-03-05`, retrieved 2026-10-31)
- Started: 2020-02-10 (actual) (ClinicalTrials.gov record NCT04714736, source copy `cardio:ctgov-nct04714736-2024-03-05`, retrieved 2026-10-31)
- Primary completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT04714736, source copy `cardio:ctgov-nct04714736-2024-03-05`, retrieved 2026-10-31)
- Completion: 2023-12-31 (actual) (ClinicalTrials.gov record NCT04714736, source copy `cardio:ctgov-nct04714736-2024-03-05`, retrieved 2026-10-31)
- Countries: Italy (ClinicalTrials.gov record NCT04714736, source copy `cardio:ctgov-nct04714736-2024-03-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04714736-2024-03-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: DyeVert System and Contrast-induced Acute Kidney Injury
- Acronym: REMEDIALIV
- Condition: Contrast-induced Acute Kidney Injury
- Condition: Acute Coronary Syndromes
- Intervention (Device): Coronary angiography using DyeVert system
- Intervention (Procedure): Coronary angiography using conventional manual injection syringe.
- Lead sponsor: Clinica Mediterranea
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes (`cardio:pubmed-38479953`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 01f212409a86703bf55396de493245f1b3ca9f61c0593c2eac4088f97065ed12
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
